Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications

Esophageal cancer (EC) presents substantial therapeutic challenges due to its high mortality rate and the tendency for diagnosis at advanced stages. Acknowledging the constraints of the existing current treatment paradigm, there is a pressing need for the development of innovative, targeted therapeu...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenglin He, Yishuo Ji, Yutong Yuan, Tianfang Liang, Chenglin Liu, Yiping Jiao, Yimeng Chen, Yiming Yang, Liang Han, Yue Hu, Xianling Cong
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1532558/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582916902748160
author Zhenglin He
Yishuo Ji
Yutong Yuan
Tianfang Liang
Chenglin Liu
Yiping Jiao
Yimeng Chen
Yiming Yang
Liang Han
Liang Han
Yue Hu
Yue Hu
Xianling Cong
Xianling Cong
Xianling Cong
author_facet Zhenglin He
Yishuo Ji
Yutong Yuan
Tianfang Liang
Chenglin Liu
Yiping Jiao
Yimeng Chen
Yiming Yang
Liang Han
Liang Han
Yue Hu
Yue Hu
Xianling Cong
Xianling Cong
Xianling Cong
author_sort Zhenglin He
collection DOAJ
description Esophageal cancer (EC) presents substantial therapeutic challenges due to its high mortality rate and the tendency for diagnosis at advanced stages. Acknowledging the constraints of the existing current treatment paradigm, there is a pressing need for the development of innovative, targeted therapeutic strategies to surpass the current stagnation in survival rate improvements. Recently, microRNAs (miRNAs) have attracted significant attention for their capacity to regulate gene expression at the post-transcriptional level, thereby influencing various cellular processes. In this review, we provide a comprehensive analysis of the role of miRNAs in EC, emphasizing their mechanisms in tumorigenesis, their potential as diagnostic and prognostic biomarkers, and their influence on resistance to therapy. We elucidate how miRNAs modulate oncogenic pathways and tumor suppressor genes, influencing EC cell behavior and treatment outcomes. By integrating insights from genetic sequencing and molecular biology, we identify key miRNAs that promote or inhibit EC progression and treatment resistance. This review highlights critical need for an enhanced understanding of miRNAs in EC, advocating for their integration into therapeutic strategies.
format Article
id doaj-art-d52655d9bafb47f699dd43d89f447148
institution Kabale University
issn 1663-9812
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-d52655d9bafb47f699dd43d89f4471482025-01-29T06:45:58ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011610.3389/fphar.2025.15325581532558Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applicationsZhenglin He0Yishuo Ji1Yutong Yuan2Tianfang Liang3Chenglin Liu4Yiping Jiao5Yimeng Chen6Yiming Yang7Liang Han8Liang Han9Yue Hu10Yue Hu11Xianling Cong12Xianling Cong13Xianling Cong14China-Japan Union Hospital of Jilin University, Jilin University, Changchun, ChinaThe First Bethune Hospital of Jilin University, Jilin University, Changchun, ChinaThe First Bethune Hospital of Jilin University, Jilin University, Changchun, ChinaThe Second Bethune Hospital of Jilin University, Jilin University, Changchun, ChinaChina-Japan Union Hospital of Jilin University, Jilin University, Changchun, ChinaChina-Japan Union Hospital of Jilin University, Jilin University, Changchun, ChinaChina-Japan Union Hospital of Jilin University, Jilin University, Changchun, ChinaDepartment of Cell Biology, College of Basic Medical Science, Jilin University, Changchun, ChinaChina-Japan Union Hospital of Jilin University, Jilin University, Changchun, ChinaDepartment of Pathology, China-Japan Union Hospital of Jilin University, Changchun, ChinaChina-Japan Union Hospital of Jilin University, Jilin University, Changchun, ChinaDepartment of Biobank, China-Japan Union Hospital of Jilin University, Changchun, ChinaChina-Japan Union Hospital of Jilin University, Jilin University, Changchun, ChinaDepartment of Biobank, China-Japan Union Hospital of Jilin University, Changchun, ChinaDepartment of Dermatology, China-Japan Union Hospital of Jilin University, Changchun, ChinaEsophageal cancer (EC) presents substantial therapeutic challenges due to its high mortality rate and the tendency for diagnosis at advanced stages. Acknowledging the constraints of the existing current treatment paradigm, there is a pressing need for the development of innovative, targeted therapeutic strategies to surpass the current stagnation in survival rate improvements. Recently, microRNAs (miRNAs) have attracted significant attention for their capacity to regulate gene expression at the post-transcriptional level, thereby influencing various cellular processes. In this review, we provide a comprehensive analysis of the role of miRNAs in EC, emphasizing their mechanisms in tumorigenesis, their potential as diagnostic and prognostic biomarkers, and their influence on resistance to therapy. We elucidate how miRNAs modulate oncogenic pathways and tumor suppressor genes, influencing EC cell behavior and treatment outcomes. By integrating insights from genetic sequencing and molecular biology, we identify key miRNAs that promote or inhibit EC progression and treatment resistance. This review highlights critical need for an enhanced understanding of miRNAs in EC, advocating for their integration into therapeutic strategies.https://www.frontiersin.org/articles/10.3389/fphar.2025.1532558/fullmicroRNAsesophageal cancerpathogenesisdiagnosisprognosistreatment resistance
spellingShingle Zhenglin He
Yishuo Ji
Yutong Yuan
Tianfang Liang
Chenglin Liu
Yiping Jiao
Yimeng Chen
Yiming Yang
Liang Han
Liang Han
Yue Hu
Yue Hu
Xianling Cong
Xianling Cong
Xianling Cong
Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications
Frontiers in Pharmacology
microRNAs
esophageal cancer
pathogenesis
diagnosis
prognosis
treatment resistance
title Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications
title_full Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications
title_fullStr Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications
title_full_unstemmed Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications
title_short Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications
title_sort uncovering the role of micrornas in esophageal cancer from pathogenesis to clinical applications
topic microRNAs
esophageal cancer
pathogenesis
diagnosis
prognosis
treatment resistance
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1532558/full
work_keys_str_mv AT zhenglinhe uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT yishuoji uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT yutongyuan uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT tianfangliang uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT chenglinliu uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT yipingjiao uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT yimengchen uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT yimingyang uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT lianghan uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT lianghan uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT yuehu uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT yuehu uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT xianlingcong uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT xianlingcong uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications
AT xianlingcong uncoveringtheroleofmicrornasinesophagealcancerfrompathogenesistoclinicalapplications